72 kDa type IV collagenase
72 kDa type IV collagenase (560-568) is a synthetic peptide fragment derived from the sequence of matrix metalloproteinase-2 (MMP-2), also known as gelatinase A. This peptide encompasses amino acids 560 to 568 of the 72 kDa type IV collagenase and is widely recognized for its role in studies related to extracellular matrix remodeling, protease-substrate interactions, and the regulation of metalloproteinase activity. As a defined peptide segment, it serves as a valuable tool for dissecting the structure-function relationships within the catalytic and regulatory domains of MMP-2, facilitating advanced research into the molecular mechanisms governing tissue remodeling and cellular migration.
Enzyme Mechanism Studies: As a representative peptide sequence of MMP-2, the 72 kDa type IV collagenase (560-568) fragment is frequently utilized in mechanistic investigations of metalloproteinase activity. Its defined sequence enables researchers to probe substrate specificity, binding affinities, and the catalytic process of MMP-2 at the molecular level. By serving as a model substrate or inhibitor in in vitro assays, the peptide aids in elucidating the dynamics of enzyme-substrate interactions, contributing to a deeper understanding of proteolytic regulation within the extracellular matrix.
Protein-Protein Interaction Analysis: The peptide fragment is instrumental in mapping interaction sites between type IV collagenase and its physiological substrates or regulatory partners. Through affinity binding studies, surface plasmon resonance, or co-immunoprecipitation assays, the 560-568 sequence can be used to identify critical contact points that mediate complex formation. This approach supports the identification of allosteric modulators and enhances the rational design of molecules that may influence metalloproteinase function in a controlled research context.
Antibody Epitope Mapping: The 72 kDa type IV collagenase (560-568) peptide is commonly applied in the generation and characterization of sequence-specific antibodies. By serving as an immunogenic epitope, it facilitates the production of monoclonal or polyclonal antibodies with high specificity for the corresponding region of MMP-2. Such antibodies are invaluable for immunodetection, quantification, and localization of the enzyme in various biological samples, thereby supporting studies of MMP-2 distribution and regulation in tissue remodeling and disease models.
Peptide-Based Inhibitor Development: Researchers employ this defined peptide sequence as a scaffold or reference point in the design of selective inhibitors targeting MMP-2. By mimicking native substrate motifs, the peptide allows for the systematic evaluation of structure-activity relationships and the screening of small molecule libraries for compounds that disrupt enzyme activity. This application is particularly relevant in biochemical assays aimed at understanding the inhibitory mechanisms and specificity determinants of metalloproteinases.
Structural Biology and Conformational Analysis: The 560-568 peptide fragment provides a tractable model for structural investigations using techniques such as NMR spectroscopy or X-ray crystallography. Its well-defined sequence enables detailed analysis of conformational preferences, secondary structure elements, and potential post-translational modifications. Insights gained from these studies inform broader efforts to model the three-dimensional architecture of type IV collagenase and its functional domains, advancing the field of protein engineering and molecular design.
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More